Return to list of speakers..

Click here for: BIOGRAPHY

Click here for: ABSTRACT

Biography:

Dr Luciano Gobbi has over 25 years of experience in Field Technical Advice and New Product Development for veterinary medicines with assignments either in Italy and in several other countries abroad.

He obtained his Doctor’s Degree in Veterinary Medicine from University of Parma (Italy) and he has a Post-Graduate Diploma in Avian Pathology from University of Milan (Italy). Since graduation he has worked for a number of multinational companies within the pharmaceutical industry including Glaxo Animal Health, Pitman-Moore, Mallinckrodt Veterinary, where he held a number of technical and management positions within Technical Support, Regulatory Affairs and Clinical Trials.

He joined Schering-Plough Animal Health in 1998 and in 2005 he was named Technical Services Manager with responsibility for the Product Development and Technical Services for the Poultry Business Unit. Dr Gobbi is a member of a company international team, that in 2001 successfully completed the market introduction of anticoccidial vaccines. The team is now actively involved in the product development for innovative chicken intestinal health remedies.

He is also the company representative within the IFAH In-feed Working Group.

---

Return to top of page

Abstract:

Title: Coccidiosis control – a sanitary approach or a management approach?

Focus: Traditionally, Coccidiosis has been controlled with the use of in-feed drugs. Today, more producers are turning to vaccination for control of the disease, which enables birds to build immunity against the parasite Eimeria naturally.

The use of a live attenuated anticoccidial vaccine (Paracox-5) in broiler chickens is steadily gaining ground as more producers learn about its advantages.

Numerous studies have shown that Paracox-5 is not only safe for birds, but that chickens receiving Coccidiosis vaccination perform as just as well or better than birds raised with in-feed drugs for Coccidiosis control (hence the sanitary approach is met).

However, vaccination has other advantages for the poultry industry and focus is presented on them.

In fact, it eliminates the problem of Eimeria resistance that has occurred with in-fed anticoccidials. In addition, there is no withdrawal time and no meat residues with the vaccine as there is with drugs, so producers can be flexible about, when they manufacture poultry diets and, above all, when they send their birds to market and can better meet market demand as it arise.

The modern broiler chicken production needs a long-term Coccidiosis control and it is looking forward to utilise approaches and methods that fully guarantee a real global management approach of the disease.

Return to top of page